Pharmaceutical Technology

OCTOBER 21, 2022

With Susvimo (ranibizumab sustained release) winning US FDA approval last year, followed by an FDA approval for Vabysmo (faricimab) this year, Roche had all the right assets to take the game to the current market leader, Regeneron and Bayer’s Eylea (aflibercept), at an accelerated pace.

Physicians 59

Physicians Patients FDA Competition 59

European Pharmaceutical Review

NOVEMBER 8, 2022

For example, the US recently passed the Inflation Reduction Act, 1 which requires the Secretary of Health and Human Services (HHS) to negotiate prices for certain physician-administered and retail prescription drugs covered under Medicare Parts B and D. Citizen Petitions before the FDA. 5) monitoring access to biosimilars.

Food and Drug Administration 52

Food and Drug Administration Pharma Manufacturing Prescription 52

LEVO Health

OCTOBER 26, 2022

You need a marketing strategy that sets your medical device apart from the competition. Food & Drug Administration (FDA) classifies medical devices. How the FDA Classifies Medical Devices. The FDA classifies medical devices into one of three classes based on their risks and regulatory controls: .

Medical 52

Medical Marketing Patients Food and Drug Administration 52

Nixon Gwilt Law

NOVEMBER 16, 2021

If you are in the digital health industry, particularly the remote patient monitoring (“RPM”) space, you have likely heard of the remote therapeutic monitoring (“RTM”) codes finalized in the 2022 Medicare Physician Fee Schedule Final Rule (the “Final Rule”). blood pressure monitors and pulse oximeters) as a new service line?

Physicians 52

Physicians FDA Medical Patients 52

Pharmaceutical Representative Training

DECEMBER 28, 2021

Before 2020, the landscape of drug marketing involved following drug approvals by the Food and Drug Administration ( FDA ), finding which patient population would benefit from therapy, and visiting specialized doctors in-person to advertise its advantages compared to current guidelines. The technology identifies.

Marketing 52

Marketing Food and Drug Administration Pharma Doctors 52

Pharma Marketing Network

APRIL 10, 2023

Instead of turning to government-funded healthcare, we should focus on increasing competition in the healthcare market. By allowing for more competition, healthcare costs will decrease, and citizens will have more options for their healthcare needs. The last thing we need is to burden our citizens with even more taxes.

Government 52

Government Healthcare Healthcare Competition 52

Pharmaceutical Technology

OCTOBER 5, 2022

As per the US Department of Justice, Biogen paid remuneration in the form of training and consulting fees and speaker honoraria, to induce physicians to prescribe the company’s drugs, in violation of the Anti-Kickback Statute. More recently, Biogen has been facing competition from dimethyl fumarate generics.

Government 59

Government Specialization Physicians Education 59

Pharmaceutical Technology

JANUARY 10, 2023

Type 2 diabetes (T2D) is a crowded and competitive landscape with multiple “me-too,” generic and biosimilar drugs entering the market, with market growth primarily driven by an increasing prevalent population across nine major markets (9MM: US, France, Germany, Italy, Spain, UK, Japan, China, and India).

Marketing 52

Marketing Physicians Sales Leads 52

Pharma Marketing Network

APRIL 1, 2023

With a focus on marketing and digital health, Pharma-Mkting.com provides a wealth of information, resources, and insights to help these industries succeed in an increasingly competitive market. One of the key areas of expertise for Pharma-Mkting.com is pharmaceutical marketing.

Medical 52

Medical Pharma Pharmaceutical Marketing 52

Pharmaceutical Technology

SEPTEMBER 13, 2022

A global Phase III TROPiCS-02 study evaluated the use of Trodelvy in comparison to physicians’ choice of chemotherapy in 543 HR+/HER2- metastatic breast cancer patients who were previously treated with endocrine therapy, CDK 4/6 inhibitors and at least two lines of chemotherapy. months) versus physicians’ choice chemotherapy (11.2

Competition 64

Competition Marketing Food and Drug Administration Physicians 64

Infuse Medical

JANUARY 9, 2020

Plan Ahead Before FDA Approval. Medical device products require approval by the Food and Drug Administration (FDA) before they go to market. With an unpredictable FDA timeline, the launch date could come sooner than you think. We recommend creating a plan with deadlines before FDA approval. Know Your Competition.

Training 52

Training Food and Drug Administration Sales Marketing 52

Clarivate

JUNE 28, 2024

The quality of training data is another significant hurdle, while the knowledge and trust of physicians in AI-supported systems can also pose a challenge. These tools, powered by advanced machine learning algorithms, have garnered widespread acclaim, with numerous FDA approvals, particularly in radiology.

Healthcare 52

Healthcare Healthcare Healthcare Provider Medical 52

Nixon Gwilt Law

SEPTEMBER 5, 2024

Leverage Non-Dilutive Funding Explore grants, accelerators, and competitions that offer non-dilutive funding options. Ensure that your financial relationships with physicians are structured to comply with these regulations. We’ll help you develop and refine your regulatory strategy across the board, from FDA to HIPAA to CMS and more.

Healthcare 52

Healthcare Healthcare Government Marketing 52

pharmaphorum

DECEMBER 15, 2022

Back in 2015, the influencer-of-influencers, Kim Kardashian, was slammed for failing to mention the potential side effects of an anti-nausea drug, leading to the US FDA getting involved. When well executed, social listening can be used to inform market research, competitive intelligence, brand planning, and congress engagement initiatives.

Media 102

Media Healthcare Healthcare Education 102

Legacy MEDSearch

MAY 4, 2023

Moran’s strong track record of leading the evolution of a company from clinical product development through commercialization, and experience successfully navigating multiple FDA clearances, CE marks and global expansion, will be invaluable to Avertix as the company continues to grow and expand its market share.

Medical 52

Medical Management Recruitment Patients 52

Rep-Lite

MARCH 14, 2024

Skill Set Mastery Mastering the following skills can turn a regular medical sales representative into a successful one in this competitive field. This also requires medical sales representatives to be familiar with clinical data based on research and FDA regulations to ensure compliance.

Medical sales reps 52

Medical sales reps Medical sales Sales Medical 52

Infuse Medical

SEPTEMBER 17, 2020

Sales reps are usually at the forefront of this pressure and have to work hard to make sure the product’s value is understood while adhering to the FDA regulations. According to the Journal of Medical Research , over 67% of physicians use social media for professional use. We’ve Got Your Medical Technology Needs Covered.

Pharmaceutical Sales 52

Pharmaceutical Sales Sales Medical Pharmaceutical 52

Clarivate

OCTOBER 10, 2022

Based on the TROPICS-02 trial results, Gilead has submitted a supplemental biologics license application (sBLA) to the FDA, seeking a label expansion for TRODELVY in the much larger setting of metastatic HR+/HER2-negative breast cancer. Fruquintinib will face fierce competition should it be approved in the third- and later-line setting.

Marketing 52

Marketing Safety Patients Competition 52

Impetus Digital

JANUARY 3, 2023

Back in 2015, the influencer-of-influencers, Kim Kardashian, was slammed for failing to mention the potential side effects of an anti-nausea drug, leading to the US FDA getting involved. When well executed, social listening can be used to inform market research, competitive intelligence, brand planning, and congress engagement initiatives.

Media 52

Media Healthcare Healthcare Recruitment 52

Contrarian Sales Techniques

DECEMBER 14, 2022

Other factors such as the generic competition for older drugs and the pricing pressure are also contributing to the industry's decline. In 2021, the demand for physician-administered drugs decreased due to the outbreak. The US Food and Drug Administration (FDA) has approved Wegovy, which is a 2.4-mg

Food and Drug Administration 52

Food and Drug Administration Pharmaceutical Sales Medicine 52

Clarivate

AUGUST 27, 2024

FDA approval in January 2024. reported having already switched 50% to 70% of their cardiac ablations to PFA – just two months after the launch of the two currently FDA-approved systems, Medtronic plc’s PulseSelect and Boston Scientific Corp.’s Boston Scientific Corp. received CE mark (i.e., in December 2023. s Farapulse. What’s next?

Marketing 52

Marketing Competition FDA Electronics 52

Evolve Your Success

OCTOBER 3, 2023

Veronica discusses a revolutionary technology for testing and how it’s transforming the way physicians and patients approach cancer treatment. As the episode unfolds, Veronica talks about the future of diagnostic testing, where it’s headed, and the potential it holds for patients and physicians alike.

Sales 64

Sales Medical sales Physicians Patients 64

Evolve Your Success

OCTOBER 31, 2023

The perfect blend of persistent dedication, a heartwarming touch of southern hospitality, and an innate understanding of the needs of both physicians and patients. They lacked those people because we know a lot about the technology and how to interact with physicians so they bring us over. We assist with training the physicians.

Engineering 52

Engineering Sales Medical sales Medical 52

PM360

NOVEMBER 29, 2022

1 And, on average , the FDA approved 60% more drugs between 2010-2019 than the yearly average over the previous decade. In fact, the pharmaceutical industry’s development pipeline has reached an all-time high of 20,109 products under active development at the end of January 2022, an increase of 500 from 2021.

Medical science 95

Medical science Medical Customer Relationship Management Doctors 95

Evolve Your Success

JANUARY 23, 2024

It’s trying to do all the processing of the physician in their brain as how they would want to do it and telling a digital or software robot to do it on their behalf, and it works. Would you say it’s saving physicians time, money, and all the above? I’m assuming you’ve talked to 100 physicians by now.

Medical sales 52

Medical sales Sales Medical Physicians 52

Clarivate

MAY 24, 2023

A narrow FDA AdComm vote in favor of accelerated approval for Sarepta’s first-in-class gene transfer therapy illustrates challenges faced by regulators, payers and developers as a wave of innovative genetic treatments for rare diseases comes to market.

Patients 52

Patients Food and Drug Administration Biopharma FDA 52

Pharmaceutical Technology

OCTOBER 25, 2022

Understanding both the significant competitive advantages that FDC products can offer, and the difficulties and potential pitfalls associated with development and manufacturing of FDC drugs in oral solid dosage forms is a critical first step for companies exploring this approach. Pharmaceutical companies – and the FDA – are embracing FDCs.

Manufacturing 52

Manufacturing Physicians Prescription FDA 52

Evolve Your Success

APRIL 11, 2023

My partner is an emergency medicine physician. We have launched into the US marketplace and got the product design through FDA. Those revisits that healthcare facilities and physicians have are not covered. Sometimes they go back to the primary care physician to do it. You can do that up to five times.

Sales 52

Sales Medical Media Medical sales 52

pharmaphorum

JUNE 29, 2022

Non-COVID prescription medicines didn’t stop launching during the pandemic — approvals by both the FDA and the EMA were, in fact historically high in both 2020 and 2021. The scope of the problem. The post-pandemic launch pipeline remains strong in numbers and quality, diverse in launch type, and continues to address severe unmet needs.

Doctors 57

Doctors Medicine Marketing Sales 57

Evolve Your Success

OCTOBER 24, 2023

We may not be aware of that next-gen situation, or perhaps it’s a competitive situation or what have you. A lot of times, these are very confidential programs because their competition is so fierce. It’s pretty competitive. They understand the American and European requirements of the FDA and the EU. L et’s go back.

Sales 64

Sales Medical Manufacturing Medical sales 64

Clarivate

OCTOBER 7, 2021

Based on the KEYNOTE-716 data, it is anticipated that Keytruda will gain a label expansion in this patient setting, with FDA priority review status and a PDUFA date set for December 2021. Kisqali plus letrozole demonstrated a significant OS benefit, but is that enough to displace physician favorite Ibrance?

Patients 91

Patients Safety Marketing Physicians 91

Nixon Gwilt Law

JANUARY 16, 2024

Companies will also need to understand whether the FDA will consider their model to be software as a medical device (SaMD) that is subject to the FD&C Act. Competition will drive down consumer prices but drive up insurance costs (especially for employers). We wrote about new Medicare coverage for emerging DTx technologies here.

Healthcare 52

Healthcare Healthcare Management Insurance 52

Cadensee

JULY 20, 2021

Basically, I started teaching myself how to get good information outside the internet and see how that empowers us with our discussion with a physician with everything that we did. So, you see on one side, there's a special body of the FDA trying to listen to patients to find new targets for health and for pharmaceutical technology.

Food and Drug Administration 52

Food and Drug Administration Doctors Healthcare Healthcare 52

Clarivate

AUGUST 20, 2024

In 2026, CMS will select up to 15 additional Part B or Part D drugs for negotiations that take effect in 2028, and up to 20 additional drugs every year thereafter (Part B covers physician-administered drugs, including infusions of complex biologics). In highly competitive categories like diabetes, net price could be half of the list price.

Manufacturing 52

Manufacturing Government Prescription Pharmaceutical manufacturing 52

Pharmaceutical Technology

DECEMBER 4, 2022

There are seven FDA-approved Humira biosimilars, of which Amgen’s Amjevita will be launched in January. Others are made by big pharma giants like Boehringer Ingelheim , Novartis , or Pfizer , which has raised the expectations for a competitive market. . Even some physicians remain hesitant about biosimilars in general.

Marketing 104

Marketing Physicians Competition Patients 104

Clarivate

DECEMBER 14, 2023

The weight loss drug conundrum PBMs may rethink their coverage policies for GLP-1 receptor agonists after the November 2023 approval of Eli Lilly’s Zepbound whose active ingredient was already available as diabetes drug Mounjaro ® and which joins Novo Nordisk’s Wegovy ® among the latest class of FDA-approved options.

Marketing 52

Marketing Healthcare Healthcare Insurance 52